S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
"Prepare for Five Years of Famine" (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
Don't Be Fooled by These 3 Value Traps
"Prepare for Five Years of Famine" (Ad)
The Bottom Is In For McCormick & Company
3 More Downgrades To Put On Your Buy List 
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
"Prepare for Five Years of Famine" (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
Don't Be Fooled by These 3 Value Traps
"Prepare for Five Years of Famine" (Ad)
The Bottom Is In For McCormick & Company
3 More Downgrades To Put On Your Buy List 
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
"Prepare for Five Years of Famine" (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
Don't Be Fooled by These 3 Value Traps
"Prepare for Five Years of Famine" (Ad)
The Bottom Is In For McCormick & Company
3 More Downgrades To Put On Your Buy List 
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
"Prepare for Five Years of Famine" (Ad)
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
A 100% Win Rate In 2022… (Ad)pixel
3 Undervalued Dividend Payers For Volatile Market Conditions
Don't Be Fooled by These 3 Value Traps
"Prepare for Five Years of Famine" (Ad)
The Bottom Is In For McCormick & Company
3 More Downgrades To Put On Your Buy List 
NYSE:ZVO

Zovio - ZVO Stock Forecast, Price & News

$0.0052
0.00 (0.00%)
(As of 03/28/2023 12:00 AM ET)
Add
Today's Range
$0.0052
$0.0060
50-Day Range
$0.0060
$0.0150
52-Week Range
$0.08
$1.79
Volume
8,904 shs
Average Volume
2.07 million shs
Market Capitalization
$177,949.20
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ZVO stock logo

About Zovio (NYSE:ZVO) Stock

Zovio, Inc. operates as an education technology services company that partners with higher education institutions and employers to deliver solutions and learning experiences. It provides student recruitment and enrollment systems, retention strategies, educational tools, and curriculums. The company was founded by Wayne Clugston and Andrew S. Clark in May 1999 and is headquartered in Chandler, AZ.

Receive ZVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zovio and its competitors with MarketBeat's FREE daily newsletter.

ZVO Stock News Headlines

StockNews.com Begins Coverage on Zovio (NYSE:ZVO)
See More Headlines
Receive ZVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zovio and its competitors with MarketBeat's FREE daily newsletter.

ZVO Company Calendar

Today
3/29/2023
Next Earnings (Estimated)
4/13/2023

Industry, Sector and Symbol

Industry
Colleges, Universities, and Professional Schools
Sub-Industry
N/A
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$230.00 million

Miscellaneous

Free Float
N/A
Market Cap
$177,949.20
Optionable
Optionable
Beta
1.36

Key Executives

  • Randy J. Hendricks
    Chief Executive Officer & Director
  • Kevin S. Royal
    Chief Financial Officer & Executive Vice President
  • Vickie L. Schray
    Chief External Affairs Officer & Executive VP
  • John W. Semel
    Chief Strategy Officer & Executive Vice President
  • Matthew D. Mitchell
    Secretary, Senior Vice President & General Counsel













ZVO Stock - Frequently Asked Questions

How have ZVO shares performed in 2023?

Zovio's stock was trading at $0.0085 on January 1st, 2023. Since then, ZVO shares have decreased by 38.8% and is now trading at $0.0052.
View the best growth stocks for 2023 here
.

When is Zovio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 13th 2023.
View our ZVO earnings forecast
.

What other stocks do shareholders of Zovio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zovio investors own include Advanced Micro Devices (AMD), Telefonaktiebolaget LM Ericsson (publ) (ERIC), Pfizer (PFE), Zynga (ZNGA), CymaBay Therapeutics (CBAY), Remark (MARK), Himax Technologies (HIMX), Moderna (MRNA), Bank of America (BAC).

What is Zovio's stock symbol?

Zovio trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZVO."

Who are Zovio's major shareholders?

Zovio's stock is owned by a number of retail and institutional investors. Top institutional investors include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Zovio?

Shares of ZVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zovio's stock price today?

One share of ZVO stock can currently be purchased for approximately $0.01.

How much money does Zovio make?

Zovio (NYSE:ZVO) has a market capitalization of $177,949.20 and generates $230.00 million in revenue each year.

How can I contact Zovio?

The company can be reached via phone at (858) 668-2586.

This page (NYSE:ZVO) was last updated on 3/29/2023 by MarketBeat.com Staff